Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altorki, N. K.
Right arrow Articles by Skinner, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altorki, N. K.
Right arrow Articles by Skinner, D. B.
(Chest. 1994;106:742-745.)
© 1994 American College of Chest Physicians

Esophageal Carcinoma with Airway Invasion

Evolution and Choices of Therapy

Nasser K. Altorki M.D.1; Marcello Migliore M.D.1; and David B. Skinner M.D.1

1 From the New York Hospital-Cornell Medical Center, New York

In order to define the evolution of airway invasion by esophageal cancer, we reviewed 53 patients presenting with (group A) or without (group B) tracheoesophageal fistulae. Patients in group A were treated by esophageal bypass (4), esophageal diversion (4), expectant therapy (4), or esophageal prosthesis (1). The median survival was 4 months. Group B patients were treated by esophageal resection (18), esophageal bypass (4), or radiation therapy (13), depending on the extent of local disease. Bronchoscopy was a valuable tool for predicting resectability. Surgical resection, when possible, yielded better palliation. There were 4 long-term survivors in group B.

Submitted on October 28, 1993
Accepted on January 4, 1994




This article has been cited by other articles:


Home page
ChestHome page
H. Dutau, B. Toutblanc, C. Lamb, and L. Seijo
Use of the Dumon Y-stent in the Management of Malignant Disease Involving the Carina: A Retrospective Review of 86 Patients
Chest, September 1, 2004; 126(3): 951 - 958.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Riedel, H. J. Stein, L. Mounyam, R. Lembeck, and J. R. Siewert
Extensive Sampling Improves Preoperative Bronchoscopic Assessment of Airway Invasion by Supracarinal Esophageal Cancer : A Prospective Study in 166 Patients
Chest, June 1, 2001; 119(6): 1652 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. P. Alexander, G. D. Trachiotis, T. O. Lipman, and R. G. Wadleigh
Evolving management and outcome of esophageal cancer with airway involvement
Ann. Thorac. Surg., May 1, 2001; 71(5): 1640 - 1644.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.